Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-01-11
2011-01-11
Mosher, Mary E (Department: 1648)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S135100, C435S005000, C530S387300, C530S388300, C536S023530
Reexamination Certificate
active
07867497
ABSTRACT:
The present invention is directed to particular human monoclonal antibodies and fragments thereof that find use in the detection, prevention and treatment of respiratory syncytial virus infections. In particular, these antibodies may neutralize RSV. Also disclosed are improved methods for producing monoclonal antibodies.
REFERENCES:
patent: 5639641 (1997-06-01), Pedersen et al.
patent: 5824307 (1998-10-01), Johnson
patent: 5861155 (1999-01-01), Lin
patent: 5922344 (1999-07-01), Hilty et al.
patent: 6180377 (2001-01-01), Morgan et al.
patent: 6491916 (2002-12-01), Bluestone et al.
patent: 6632927 (2003-10-01), Adair et al.
patent: 6656467 (2003-12-01), Young et al.
patent: 6685942 (2004-02-01), Burton et al.
patent: 6818216 (2004-11-01), Young et al.
patent: 6855493 (2005-02-01), Young et al.
patent: 7488477 (2009-02-01), Pilkington et al.
patent: 2004/0005323 (2004-01-01), Brams
patent: 2004/0005324 (2004-01-01), Pilkington et al.
patent: 1 659 133 (2006-05-01), None
patent: 1 997 830 (2008-12-01), None
patent: WO 2004/076677 (2004-09-01), None
patent: WO 2006/034292 (2006-03-01), None
patent: WO 2006/050280 (2006-05-01), None
patent: WO 2007/101441 (2007-09-01), None
Groothuis et al., “Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group,”New Engl. J. Med., 329:1524-1530, 1993.
Johnson et al., “Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus,”J. Infect. Diseases, 176:12151224, 1997.
Murphy et al., “An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines,”Virus Res., 32:13-36, 1994.
Murphy et al., “Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV).,”Vaccine, 9:185-189, 1991.
Murphy et al., “Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses,”J. Virol., 62:3907-3910, 1988.
Prince et al., “Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat,”Virus Res., 3:193-206, 1985.
Prince et al., “Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection of cotton rats,”J. Virol., 64:3091-3092, 1990.
Prince et al., “Mechanisms of immunity to respiratory syncytial virus in cotton rats,”Infect. Immun., 42:81-87, 1983.
Prince et al., “Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats,”J. Virol., 55:517-520, 1985.
The Prevent Study Group, “Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group,”Pediatrics, 99:93-99, 1997.
International Search Report and Written Opinion issued in Application No. PCT/US2008/077370, dated Jan. 21, 2009.
International Preliminary Report on Patentability for PCT/US2008/077721, mailed Mar. 30, 2010.
Fulbright & Jaworski
Mosher Mary E
Vanderbilt University
LandOfFree
Monoclonal antibodies to respiratory syncytial virus and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies to respiratory syncytial virus and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies to respiratory syncytial virus and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2643990